Trial
NCT05378698
Effects of Tralokinumab in the Skin: an Immunologic and Molecular Investigation
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Zurich
Collaborators
Hochgebirgsklinik Davos-Wolfgang
Condition
Atopic Dermatitis
Intervention
Application of Tralokinumab
Why stopped
treatment group completed but insufficient recruitment control group
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-02-06